Screening method for infection agent of prion disease
CA 2437016 A1 · Owner: Mohri, Shirou · Inventors: Kitamoto, Tetsuyuki; Miyoshi, Ichiro; Mohri, Shirou
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
To quickly determine the presence/absence of infection with prion in drugs such as blood preparations, foods, cosmetics etc. it is required to early , detect human prion disease infection factors such as CJD in animal models or the like. A method of screening a human or nonhuman prion disease infection factor in a sample characterized by using abnormal prion protein sedimentation in nonhuman follicular dendritic cells (FDC) as an indication.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 31, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 31, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 31, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.